Skip to main content

Polio

 


Poliomyelitis, or Polio for short is primarily known for its paralysis in patients. Poliovirus can multiply in specialised cells in the intestines which enters the bloodstream to invade the Central Nervous System, where it spreads along nerve fibres and multiplies. The virus destroys nerve cells (Motor Neurons) which cannot regenerate. Consequently, nerve impulses are unable to be transmitted to skeletal muscles, causing paralysis. 


Poliovirus also attacks the motor neurons of the brain stem, damaging breathing capacity and causing difficulty in swallowing and speaking. Without respiratory support, polio can result in death. Hence, many patients whose conditions were severe required a metallic cylinder infamously known as the “Iron Lung” for breathing support. The Iron Lung functions by creating a vacuum within itself. This air pressure in the Iron Lung will be reduced, relative to that of the atmosphere, forcing oxygen into the patient’s lungs.


Poliovirus is highly contagious. It is transmitted via oral contact with secretions or faecal material from an infected person. First outbreak of Poliovirus occurred in Vermont, USA 1894 with 132 cases. Fortunately, the onset of Oral Polio Vaccine (OPV) and Inactivated Polio Vaccine (IPV) have reduced the cases of poliomyelitis by over 99% as of 2003. Only 7 countries globally have any traceable poliovirus transmissions.


Comments

Popular posts from this blog

Parkinson's Disease

Parkinson’s disease is a progressive nervous system disorder that affects one’s movements. Parkinson’s disease signs and symptoms are different for every individual and may go unnoticed in the early stage. Symptoms typically start on one side of the body and remain worse on that side even after the symptoms begin appearing in both sides of the body.  Generally, the symptoms of Parkinson’s disease include tremors, slowed movement, rigid muscles, impaired posture and balance, loss of automatic movements such as blinking or swinging of arms when walking, and speech and writing changes.  Parkinson’s disease occurs when neurons in an area of the brain that controls movement becomes impaired or dies. These neurons normally produce dopamine. As more neurons become impaired or die, the amount of dopamine produced in the body is reduced significantly, causing the movement problems associated with Parkinson’s disease.  People with Parkinson’s also lose the nerve endings that produce norepinephri

Tinnitus

Tinnitus is a hearing condition often described as ringing in the ears. Tinnitus can also cause other types of noise in your ears such as: buzzing, roaring, clicking, hissing and humming.  The pitch heard from tinnitus can vary from a high squeal to a low roar, this can affect the patient’s ability to detect tinnitus from external sounds Tinnitus can develop gradually over time or occur suddenly. It is often associated with: age-related hearing loss, inner ear damage, earwax build-up and middle ear infection However, one in every three people with tinnitus doesn't have any obvious problem with their ears or hearing. Sources: https://www.mayoclinic.org/diseases-conditions/tinnitus/diagnosis-treatment/drc-20350162 http://www.webmd.com/a-to-z-guides/understanding-tinnitus-basics

Pompe Disease

Pompe disease is a rare genetic condition where the body is unable to break down complex sugars. This is due to a deficiency in an enzyme called acid alfa glucosidase (GAA). Mutations in the GAA gene causes this disorder and results in a build up of glycogen in cells.  Pompe disease can appear in patients from within a few months of birth, at about 1 years old and even during the teenage years.  Those with Pompe disease usually inherit the disease from their parents. However, the allele for the disease is recessive, and may not be expressed in the parents. This disease is typically associated with weak muscles, poor muscle tone and an enlarged liver. However, there are many complications with regards to the respiratory system and motor skills which can also develop.  Enzyme replacement treatment is used for all Pompe patients. A drug called aglucosidase alfa is given intravenously, which acts as a replacement for GAA. Sources: https://my.clevelandclinic.org/health/diseases/15808-pompe-